Glycyrrhizic acid in liquorice--evaluation of health hazard - PubMed (original) (raw)
Review
Glycyrrhizic acid in liquorice--evaluation of health hazard
F C Størmer et al. Food Chem Toxicol. 1993 Apr.
Abstract
Literature on case reports, clinical studies and biochemical mechanisms of the sweet-tasting compound glycyrrhizic acid in liquorice was critically reviewed to provide a safety assessment of its presence in liquorice sweets. A high intake of liquorice can cause hypermineralocorticoidism with sodium retention and potassium loss, oedema, increased blood pressure and depression of the renin-angiotensin-aldosterone system. As a consequence, a number of other clinical symptoms have also been observed. Glycyrrhizic acid is hydrolysed in the intestine to the pharmacologically active compound glycyrrhetic acid, which inhibits the enzyme 11 beta-hydroxysteroid dehydrogenase (in the direction of cortisol to cortisone) as well as some other enzymes involved in the metabolism of corticosteroids. Inhibition of 11 beta-hydroxysteroid dehydrogenase leads to increased cortisol levels in the kidneys and in other mineralocorticoid-selective tissues. Since cortisol, which occurs in much larger amounts than aldosterone, binds with the same affinity as aldosterone to the mineralocorticoid receptor, the result is a hypermineralocorticoid effect of cortisol. The inhibitory effect on 11 beta-hydroxysteroid dehydrogenase is reversible; however, the compensatory physiological mechanisms following hypermineralocorticoidism (e.g. depression of the renin-angiotensin system) may last several months. It is not possible, on the basis of existing data, to determine precisely the minimum level of glycyrrhizic acid required to produce the described symptoms. There is apparently a great individual variation in the susceptibility to glycyrrhizic acid. In the most sensitive individuals a regular daily intake of no more than about 100 mg glycyrrhizic acid, which corresponds to 50 g liquorice sweets (assuming a content of 0.2% glycyrrhizic acid), seems to be enough to produce adverse effects. Most individuals who consume 400 mg glycyrrhizic acid daily experience adverse effects. Considering that a regular intake of 100 mg glycyrrhizic acid/day is the lowest-observed-adverse-effect level and using a safety factor of 10, a daily intake of 10 mg glycyrrhizic acid would represent a safe dose for most healthy adults. A daily intake of 1-10 mg glycyrrhizic acid/person has been estimated for several countries. However, an uneven consumption pattern suggests that a considerable number of individuals who consume large amounts of liquorice sweets are exposed to the risk of developing adverse effects.
Similar articles
- Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
Cosmetic Ingredient Review Expert Panel. Cosmetic Ingredient Review Expert Panel. Int J Toxicol. 2007;26 Suppl 2:79-112. doi: 10.1080/10915810701351228. Int J Toxicol. 2007. PMID: 17613133 Review. - Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man.
Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CR. Stewart PM, et al. Clin Sci (Lond). 1990 Jan;78(1):49-54. doi: 10.1042/cs0780049. Clin Sci (Lond). 1990. PMID: 2153495 - Liquorice-induced hypertension--a new understanding of an old disease: case report and brief review.
Heikens J, Fliers E, Endert E, Ackermans M, van Montfrans G. Heikens J, et al. Neth J Med. 1995 Nov;47(5):230-4. doi: 10.1016/0300-2977(95)00015-5. Neth J Med. 1995. PMID: 8544895 - Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors.
Armanini D, Karbowiak I, Funder JW. Armanini D, et al. Clin Endocrinol (Oxf). 1983 Nov;19(5):609-12. doi: 10.1111/j.1365-2265.1983.tb00038.x. Clin Endocrinol (Oxf). 1983. PMID: 6315264 - Liquorice and its health implications.
Olukoga A, Donaldson D. Olukoga A, et al. J R Soc Promot Health. 2000 Jun;120(2):83-9. doi: 10.1177/146642400012000203. J R Soc Promot Health. 2000. PMID: 10944880 Review.
Cited by
- Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids.
Jäger MC, González-Ruiz V, Joos FL, Winter DV, Boccard J, Degenhardt T, Brand S, Rudaz S, Thompson GR 3rd, Odermatt A. Jäger MC, et al. Front Pharmacol. 2024 Aug 8;15:1394846. doi: 10.3389/fphar.2024.1394846. eCollection 2024. Front Pharmacol. 2024. PMID: 39175536 Free PMC article. - Hypokalaemia associated with excessive cola-flavoured drinks consumption.
Baba-Aissa S, Cooke L, Alner V, Ahmed MH. Baba-Aissa S, et al. BMJ Case Rep. 2024 Apr 22;17(4):e258873. doi: 10.1136/bcr-2023-258873. BMJ Case Rep. 2024. PMID: 38649244 - UiO-66 nanoparticles combat influenza A virus in mice by activating the RIG-I-like receptor signaling pathway.
Su R, Li X, Xiao J, Xu J, Tian J, Liu T, Hu Y. Su R, et al. J Nanobiotechnology. 2024 Mar 9;22(1):99. doi: 10.1186/s12951-024-02358-y. J Nanobiotechnology. 2024. PMID: 38461229 Free PMC article. - Antimicrobial Effects of Edible Mixed Herbal Extracts on Oral Microorganisms: An In Vitro Study.
Yun SE, Choi BR, Nam SH, Kim GC. Yun SE, et al. Medicina (Kaunas). 2023 Oct 4;59(10):1771. doi: 10.3390/medicina59101771. Medicina (Kaunas). 2023. PMID: 37893489 Free PMC article. - Topical Licorice for Aphthous: A Systematic Review of Clinical Trials.
Dorsareh F, Vahid-Dastjerdi G, Bouyahya A, Zarshenas MM, Rezaie M, Yang WM, Amiri-Ardekani E. Dorsareh F, et al. Iran J Med Sci. 2023 Sep;48(5):437-447. doi: 10.30476/IJMS.2022.94467.2576. Iran J Med Sci. 2023. PMID: 37786470 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials